glp-1 long-term safety As the use of medications continues to rise, researchers are exploring their potential impact on eye health. While these drugs can help manage diabetes and promote weight loss, recent studies suggest What Is Insurance Prior Authorization

doi: 10.1042/CS20220890

Researchers found that participants who took Zepbound for 18 months lost more weight (20.2% of their body weight, or an average of about 50 pounds) compared to those on Wegovy (13.7% of their body weight, or about 33 pounds on average)

Aim for 2530 grams of protein per meal, emphasizing lean meats, fish, eggs, legumes, and low-fat dairy

This means compounded versions are no longer allowed for general use

In contrast, the iShares pharmaceutical fund targets a much narrower segment of the market with its 55 holdings

Ozempic (semaglutide) and Mounjaro (tirzepatide) are both approved for blood sugar control in patients with type 2 diabetes, but they can lead to significant weight loss too (but they are not approved for that use)